Preliminary Phase 2 Results to be Presented at Biotech Showcase 2019

January 2, 2019 – Silenseed to present early Phase 2 clinical results in stage 3 pancreatic cancer. Presentation will include very preliminary clinical results from the first 11 patients enrolled in the company’ PROTACT Phase 2 clinical trial. Presentation will be given at the Biotech Showcase, the event claimed to be “The investor conference that drives the future of drug development”, at Wednesday, 11:00 AM January 9, 2019 Track: Franciscan C (Ballroom Level), Hilton Union Square San Francisco
 

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email